Inventor
SHAM HING L
US59 patents
⚠️ This page may combine multiple inventors who share the name “SHAM HING L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
47 patentsUS5354866AOct 11, 1994
Retroviral protease inhibiting compounds
ABBOTT LAB140 citations99
US7205409B2Apr 17, 2007
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB89 citations97
US6201001B1Mar 13, 2001
Imidazole antiproliferative agents
ABBOTT LAB70 citations96
US5583232ADec 10, 1996
Retroviral protease inhibiting compounds
ABBOTT LAB22 citations96
US5539122AJul 23, 1996
Retroviral protease inhibiting compounds
ABBOTT LAB32 citations96
US5461067AOct 24, 1995
Retroviral protease inhibiting compounds
ABBOTT LAB43 citations96
US6455571B1Sep 24, 2002
Inhibitors of neuraminidases
ABBOTT LAB60 citations95
US4826815AMay 2, 1989
Renin inhibiting compounds
ABBOTT LAB61 citations95
US5455351AOct 3, 1995
Retroviral protease inhibiting piperazine compounds
ABBOTT LAB24 citations93
US5256677AOct 26, 1993
Retroviral protease inhibiting compounds
ABBOTT LAB39 citations93
US5151438ASep 29, 1992
Retroviral protease inhibiting compounds
ABBOTT LAB33 citations93
US4988703AJan 29, 1991
Carbocyclic nucleoside analogs with antiviral activity
ABBOTT LAB24 citations93
US6228868B1May 8, 2001
Oxazoline antiproliferative agents
ABBOTT LAB32 citations92
US5905068AMay 18, 1999
Retroviral protease inhibiting compounds
ABBOTT LAB21 citations92
US7119205B2Oct 10, 2006
Thienopyridones as AMPK activators for the treatment of diabetes and obesity
ABBOTT LAB47 citations90
US5597928AJan 28, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB17 citations86
US5580984ADec 3, 1996
Retroviral protease inhibiting compounds
ABBOTT LAB16 citations86
US5565418AOct 15, 1996
Retroviral protease inhibiting compounds
ABBOTT LAB16 citations84
US7888374B2Feb 15, 2011
Inhibitors of c-jun N-terminal kinases
ABBOTT LAB9 citations83
US7262207B2Aug 28, 2007
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB13 citations83
US7238724B2Jul 3, 2007
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB18 citations83
US5625072AApr 29, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB15 citations82
US5616720AApr 1, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB16 citations82
US5608072AMar 4, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB15 citations82
US5597927AJan 28, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB15 citations82
US5591860AJan 7, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB16 citations82
US5583233ADec 10, 1996
Retroviral protease inhibiting compounds
ABBOTT LAB16 citations82
US5621109AApr 15, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB9 citations74
US4826958AMay 2, 1989
Renin inhibiting compounds
ABBOTT LAB11 citations74
US4725584AFeb 16, 1988
Peptidyl-1-amino-2,4-diols
ABBOTT LAB10 citations74
US7115767B2Oct 3, 2006
Tetraline derivatives as ghrelin receptor modulators
ABBOTT LAB9 citations73
US5268374ADec 7, 1993
Non-peptide renin inhibitors
ABBOTT LAB8 citations72
US7323570B2Jan 29, 2008
Farnesyltransferase inhibitors
ABBOTT LAB2 citations62
US7211595B2May 1, 2007
Farnesyltransferase inhibitors
ABBOTT LAB5 citations62
US7071182B2Jul 4, 2006
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
ABBOTT LAB6 citations62
US7056925B2Jun 6, 2006
Urea kinase inhibitors
ABBOTT LAB2 citations62
US6797825B2Sep 28, 2004
Protein kinase inhibitors
ABBOTT LAB3 citations62
US6518305B1Feb 11, 2003
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
ABBOTT LAB6 citations62
US5565604AOct 15, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB2 citations62
US6831096B2Dec 14, 2004
Inhibitors of neuraminidases
ABBOTT LAB3 citations61
US5543551AAug 6, 1996
Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
ABBOTT LAB2 citations61
US7671076B2Mar 2, 2010
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB3 citations60
US7348346B2Mar 25, 2008
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB3 citations60
US5631376AMay 20, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB0 citations52
US5616714AApr 1, 1997
Retroviral protease inhibiting compounds
ABBOTT LAB0 citations52
US5543549AAug 6, 1996
Process for the preparation of a substituted 2,5-Diamino-3-Hydroxyhexane
ABBOTT LAB0 citations52
US7049307B2May 23, 2006
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
ABBOTT LAB1 citations51
ABBOTT LABORAOTRIES
1 patentMADAR DAVID J
1 patentKEYES ROBERT F
1 patentShowing the top 50 of 59 patents by PatentIndex Score.